Cargando…

Neuroprotection by Nrf2 in Parkinson’s disease model

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Limited 2011
Materias:	In This Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180212/

Ejemplares similares

New mouse model for Parkinson’s disease
Publicado: (2013)

Neuroprotective effect of Ginsenoside Re against neurotoxin-induced Parkinson's disease models via induction of Nrf2
por: Qiao, Juhui, et al.
Publicado: (2022)

Neuroprotection of Indole-Derivative Compound NC001-8 by the Regulation of the NRF2 Pathway in Parkinson's Disease Cell Models
por: Wei, Pei-Cih, et al.
Publicado: (2019)

Astrocytic Nrf2 Mediates the Neuroprotective and Anti-Inflammatory Effects of Nootkatone in an MPTP-Induced Parkinson’s Disease Mouse Model
por: Park, Jung-Eun, et al.
Publicado: (2023)

Transcription Factor Nrf2: a novel target to modulate inflammatory and neuroprotective responses in Parkinson’s disease
por: Cuadrado, Antonio
Publicado: (2015)

The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson’s disease
por: Zhao, Miao, et al.
Publicado: (2021)

The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease
por: Zhang, Chenyu, et al.
Publicado: (2021)

Galangin Exhibits Neuroprotective Effects in 6-OHDA-Induced Models of Parkinson’s Disease via the Nrf2/Keap1 Pathway
por: Chen, Qiu-Xu, et al.
Publicado: (2022)

Therapeutic stromal nanoparticles for Parkinson’s disease
Publicado: (2014)

Açai Berry Mitigates Parkinson’s Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways
por: D’Amico, Ramona, et al.
Publicado: (2022)

Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer’s and Parkinson’s Disease: Insight into the Role of Nrf-2 and A2AR Signaling
por: Ikram, Muhammad, et al.
Publicado: (2020)

Glial Nrf2 signaling mediates the neuroprotection exerted by Gastrodia elata Blume in Lrrk2-G2019S Parkinson’s disease
por: Lin, Yu-En, et al.
Publicado: (2021)

Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP‐1 and modulating gut microbiota
por: Wu, Heng, et al.
Publicado: (2022)

Fucoxanthin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE and Nrf2-autophagy pathways
por: Zhang, Li, et al.
Publicado: (2017)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2016)

Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease
por: Grimmig, Beth, et al.
Publicado: (2017)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
por: Sheng, Xiaoyan, et al.
Publicado: (2021)

Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson's disease
por: Guo, Chao, et al.
Publicado: (2019)

Neuroprotective Effect of β-Lapachone in MPTP-Induced Parkinson’s Disease Mouse Model: Involvement of Astroglial p-AMPK/Nrf2/HO-1 Signaling Pathways
por: Park, Jin-Sun, et al.
Publicado: (2019)

Novel NRF2‐activated cancer treatments utilizing synthetic lethality
por: Baird, Liam, et al.
Publicado: (2022)

Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson’s Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk
por: Shirgadwar, Shubhendu M., et al.
Publicado: (2023)

The Promise of Neuroprotective Agents in Parkinson’s Disease
por: Seidl, Stacey E., et al.
Publicado: (2011)

Neuroprotection in Parkinson’s disease: facts and hopes
por: Salamon, András, et al.
Publicado: (2019)

Synthesis and Neuroprotective Action of Xyloketal Derivatives in Parkinson’s Disease Models
por: Li, Shichang, et al.
Publicado: (2013)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease
por: Liang, Yan, et al.
Publicado: (2019)

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
por: Giuliano, Claudio, et al.
Publicado: (2021)

Neuroprotective effert of carbon monoxide and Nrf2 in cerebral ischemia
por: Doré, Sylvain
Publicado: (2015)

Modulation of Nrf2 by Olive Oil and Wine Polyphenols and Neuroprotection
por: Martínez-Huélamo, Miriam, et al.
Publicado: (2017)

Natural Products as Modulators of Nrf2 Signaling Pathway in Neuroprotection
por: Moratilla-Rivera, Ignacio, et al.
Publicado: (2023)

Sinomenine Provides Neuroprotection in Model of Traumatic Brain Injury via the Nrf2–ARE Pathway
por: Yang, Youqing, et al.
Publicado: (2016)

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

A Multi‐Step Model of Parkinson's Disease Pathogenesis
por: Le Heron, Campbell, et al.
Publicado: (2021)

The Impact of Type 2 Diabetes in Parkinson's Disease
por: Athauda, Dilan, et al.
Publicado: (2022)

Role of Nrf2 in Parkinson’s Disease: Toward New Perspectives
por: Yang, Xin-xing, et al.
Publicado: (2022)

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
por: Markovic, Milica, et al.
Publicado: (2022)

BCG Vaccine-Induced Neuroprotection in a Mouse Model of Parkinson's Disease
por: Yong, Jing, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8afn13t7tl55jrc7p4mfbmmj0d